Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
03/2003
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024913A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY
03/27/2003WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/27/2003WO2003024437A1 Allicin
03/27/2003WO2003024404A2 Chemokines as adjuvants of immune response
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030059802 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infection of gut and intestine; for use aide in digestion and nutrient absorption
03/27/2003CA2492826A1 Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460125A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003EP1295881A1 Compositions for treating or preventing malaria and method of treating malaria
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294751A1 Dermacentor variabilis gaba-gated chloride channels
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003EP1294402A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294356A2 Sustained release delivery systems for solutes
03/26/2003EP0973756B1 Thiodepsipeptides for combating endoparasites and a method for producing the same
03/26/2003CN1406130A Veterinary compositions for the treatment of parasitic diseases
03/26/2003CN1405168A Tert-butoxy carbonyl dihydro artemisinin, preparation method and drug composition thereof
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6538031 Method of controlling sea lice infestation in fish
03/25/2003US6538013 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003CA2113908C 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2- nitroethylene derivatives for controlling fleas in domestic animals
03/20/2003WO2003022883A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022242A1 Preparation of sustained release pharmaceutical composition
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2002067951A3 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002028408A3 Compositions and methods for the transport of biologically active agents across cellular barriers
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002002089A3 Anthelmintics for preventing parasitic infections in humans and animals
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055089 Endoparasiticidal and ectoparasiticidal agents
03/20/2003US20030055053 For therapy of bacterial and protozoal infections in mammals
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054337 Malaria immunogen and vaccine
03/20/2003CA2460331A1 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system
03/20/2003CA2452194A1 Sustained release pharmaceutical compositions comprising a silicone support material
03/19/2003EP1293201A2 Use of aminoadamantane compounds as immunoregulators
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292333A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
03/19/2003EP1292306A2 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone
03/19/2003EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP0931082B1 Nodulisporic acid derivatives
03/19/2003EP0917472B1 Antiprotozoal composition
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003CN1404397A Endoparasiticidal agent composition
03/19/2003CN1404395A Antiadhesive carbohydrates
03/19/2003CN1403154A Application of Hepcidin in pharmacy
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534489 Organophosphorus compounds and the use thereof
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020037A1 Multivesicular emulsion topical delivery systems
03/13/2003WO2002078622A3 Targeted oxidative therapeutic formulation
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030049844 Recombinant canine herpesviruses
03/13/2003US20030049309 Veterinary compositions for the treatment of parasitic diseases
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289549A2 The use of plant oil-bodies in vaccine delivery systems
03/12/2003EP1289545A1 Snthetic vaccine for tick control
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003CN1402713A Control of arthropods in animals
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531501 Veterinary parasiticide
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 218